Biomarker Solutions provides clinical trial management services focused on pharmacokinetics, pharmacodynamics, and immunogenicity assessments for drug development in oncology and autoimmune diseases. The company enables clients to enhance drug discovery efficiency and reduce costs through reliable, GLP-compliant laboratory analyses and specialized animal models.
Funding
Funding not disclosed
Founders
Product
Problem
Drug development in oncology and autoimmune diseases requires comprehensive pharmacokinetic, pharmacodynamic, and immunogenicity assessments, which can be costly and time-consuming. Traditional CRO services may lack the specialized expertise and integrated platforms needed for efficient and reliable biomarker analysis. This can create bottlenecks in translational research and delay the progress of new drug candidates.
Solution
Biomarker Solutions is a contract research organization (CRO) that provides integrated preclinical and clinical bioanalytical services to accelerate drug development. The company specializes in GLP-compliant pharmacokinetic (PK), pharmacodynamic (PD), and immunogenicity (ADA/NAb) assays for cell and gene therapies (CGT) and biologics. Biomarker Solutions offers a range of services, including customized animal models, cell line development, qPCR, and omics analysis, supported by a state-of-the-art laboratory equipped with qPCR P2 facilities, cell culture rooms, and flow cytometry capabilities. By providing a comprehensive suite of bioanalytical and pharmacology services, Biomarker Solutions helps clients streamline their research, reduce costs, and meet regulatory requirements for drug approval.
Target Audience
Biomarker Solutions serves pharmaceutical and biotechnology companies involved in drug development, particularly those focused on cell and gene therapies, biologics, oncology, and autoimmune diseases.
Features
- GLP-compliant bioanalysis for preclinical and clinical studies
- Pharmacokinetic (PK) and pharmacodynamic (PD) assays
- Anti-drug antibody (ADA) and neutralizing antibody (NAb) assays
- qPCR and omics analysis for biomarker discovery
- Development of humanized animal models for oncology and autoimmune disease research
- Custom cell line construction and cell banking services
- Safety assessment studies, including general and special toxicology
- Integrated data analysis and reporting